Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRSP NYSE:NIO NYSE:TWLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRSPCRISPR Therapeutics$54.83+4.6%$52.34$34.87▼$78.48$5.29B1.741.89 million shs1.73 million shsNIONIO$5.87-0.1%$5.88$3.34▼$8.02$13.48B0.9742.27 million shs18.81 million shsTWLOTwilio$201.74+2.4%$133.63$91.84▼$203.71$30.57B1.322.54 million shs2.87 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRSPCRISPR Therapeutics-4.83%+0.15%+5.47%+7.55%+52.98%NIONIO-0.51%-8.09%-4.23%+16.53%+53.46%TWLOTwilio+2.89%+32.99%+48.61%+71.17%+90.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRSPCRISPR Therapeutics$54.83+4.6%$52.34$34.87▼$78.48$5.29B1.741.89 million shs1.73 million shsNIONIO$5.87-0.1%$5.88$3.34▼$8.02$13.48B0.9742.27 million shs18.81 million shsTWLOTwilio$201.74+2.4%$133.63$91.84▼$203.71$30.57B1.322.54 million shs2.87 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRSPCRISPR Therapeutics-4.83%+0.15%+5.47%+7.55%+52.98%NIONIO-0.51%-8.09%-4.23%+16.53%+53.46%TWLOTwilio+2.89%+32.99%+48.61%+71.17%+90.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRSPCRISPR Therapeutics 2.56Moderate Buy$65.9420.26% UpsideNIONIO 2.38Hold$6.8015.94% UpsideTWLOTwilio 2.87Moderate Buy$188.85-6.39% DownsideCurrent Analyst Ratings BreakdownLatest NIO, TWLO, and CRSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026TWLOTwilio Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$210.00 ➝ $230.005/6/2026TWLOTwilio Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C)5/6/2026CRSPCRISPR Therapeutics CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$80.00 ➝ $82.005/1/2026NIONIO Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/1/2026TWLOTwilio TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$160.00 ➝ $210.005/1/2026TWLOTwilio Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$200.005/1/2026TWLOTwilio Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$200.005/1/2026TWLOTwilio OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$200.005/1/2026TWLOTwilio KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$156.00 ➝ $200.005/1/2026TWLOTwilio BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$175.00 ➝ $215.005/1/2026TWLOTwilio Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$175.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRSPCRISPR Therapeutics$1M5,288.30N/AN/A$18.81 per share2.91NIONIO$87.49B0.15N/AN/A$0.26 per share22.56TWLOTwilio$5.30B5.77$6.85 per share29.43$51.38 per share3.93Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRSPCRISPR Therapeutics-$581.60M-$6.22N/AN/AN/A-13,856.54%-25.66%-20.39%5/11/2026 (Estimated)NIONIO-$2.14B-$0.97N/AN/AN/A-17.21%-924.56%-13.91%6/2/2026 (Estimated)TWLOTwilio$33.83M$0.64315.2255.123.981.96%4.64%3.76%N/ALatest NIO, TWLO, and CRSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/2/2026Q1 2026NIONIO-$0.0750N/AN/AN/A$3.65 billionN/A5/4/2026Q1 2026CRSPCRISPR Therapeutics-$1.2185-$1.28-$0.0615-$1.28$6.06 million$1.46 million4/30/2026Q1 2026TWLOTwilio$1.27$1.50+$0.23$0.57$1.34 billion$1.41 billion3/31/2026Q1 2026CRSPCRISPR TherapeuticsN/A-$1.28N/A-$1.28N/A$1.46 million2/14/2026Q4 2025NIONION/A$0.0410N/A$0.01N/A$4.95 billion2/13/2026Q4 2025CRSPCRISPR Therapeutics-$1.15-$1.37-$0.22-$1.37$4.72 million$0.86 million2/12/2026Q4 2025TWLOTwilio$1.24$1.33+$0.09-$0.30$1.32 billion$1.37 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCRSPCRISPR TherapeuticsN/AN/AN/AN/AN/ANIONION/AN/AN/AN/AN/ATWLOTwilioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRSPCRISPR Therapeutics0.3217.9713.32NIONIO2.080.980.87TWLOTwilio0.134.664.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRSPCRISPR Therapeutics69.20%NIONIO48.55%TWLOTwilio84.27%Insider OwnershipCompanyInsider OwnershipCRSPCRISPR Therapeutics4.30%NIONIO1.00%TWLOTwilio0.21%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRSPCRISPR Therapeutics46096.45 million92.30 millionOptionableNIONIO35,0322.30 billion2.27 billionOptionableTWLOTwilio5,587151.51 million151.20 millionOptionableNIO, TWLO, and CRSP HeadlinesRecent News About These CompaniesBank of America has a blunt message for Twilio stock investors2 hours ago | thestreet.comSalesCloser Announces Collaboration with Twilio to Accelerate Customer Deployments2 hours ago | globenewswire.comShareholders Can Be Confident That Twilio's (NYSE:TWLO) Earnings Are High QualityMay 8 at 11:49 AM | finance.yahoo.comHere's Why Twilio (TWLO) is a Strong Momentum StockMay 8 at 10:51 AM | zacks.comTwilio (TWLO) Receives a Buy from Rosenblatt SecuritiesMay 8 at 6:49 AM | theglobeandmail.comPrincipal Financial Group Inc. Acquires 98,092 Shares of Twilio Inc. $TWLOMay 8 at 6:01 AM | marketbeat.comErika Rottenberg Sells 1,500 Shares of Twilio (NYSE:TWLO) StockMay 8 at 5:25 AM | americanbankingnews.comTwilio's Long-Term AI Upside Seen Limited as Gains Prove Volume-Driven, RBC SaysMay 7 at 1:30 PM | finance.yahoo.comTwilio (NYSE:TWLO) Given New $230.00 Price Target at Rosenblatt SecuritiesMay 7 at 10:03 AM | marketbeat.comNorthland Securities Cuts Earnings Estimates for TwilioMay 7 at 7:48 AM | marketbeat.comTwilio (NYSE:TWLO) Reaches New 52-Week High - Here's What HappenedMay 7 at 6:48 AM | marketbeat.comInsider Selling: Twilio (NYSE:TWLO) Director Sells 1,500 Shares of StockMay 6 at 6:07 PM | marketbeat.comTwilio Just Reported Its Fastest Growth Since 2022. AI Is Helping, Not Hurting, TWLO Stock.May 6 at 5:29 PM | barchart.comTwilio’s Next Generation Platform: An Infrastructure Layer for Every Conversation in the Agentic EraMay 6 at 12:28 PM | finance.yahoo.comTwilio Inc. (TWLO) Is a Trending Stock: Facts to Know Before Betting on ItMay 6 at 12:28 PM | finance.yahoo.comTwilio Inc. (TWLO) Is a Trending Stock: Facts to Know Before Betting on ItMay 6 at 10:00 AM | zacks.comEquities Analysts Offer Predictions for Twilio Q3 EarningsMay 6 at 7:59 AM | marketbeat.comTruist Financial Corp Purchases 19,916 Shares of Twilio Inc. $TWLOMay 6 at 5:56 AM | marketbeat.comAnalysts Have Conflicting Sentiments on These Technology Companies: Western Digital (WDC), Twilio (TWLO) and Broadridge Financial Solutions (BR)May 5 at 10:37 AM | theglobeandmail.comIs Twilio (TWLO) One of the Best Enterprise Software Stocks to Buy?May 5 at 10:37 AM | finance.yahoo.comStrs Ohio Has $11.62 Million Position in Twilio Inc. $TWLOMay 5 at 6:03 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWith Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?By Sam Quirke | April 12, 20263 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026Why Twilio Is Rallying While the Rest of SaaS Struggles By Sam Quirke | April 13, 20263 Biotech Stocks That Could Benefit from the Patent CliffBy Chris Markoch | April 27, 2026Old Money, New Tech: Western Union's Crypto RebootBy Jeffrey Neal Johnson | May 6, 2026NIO, TWLO, and CRSP Company DescriptionsCRISPR Therapeutics NASDAQ:CRSP$54.83 +2.41 (+4.60%) Closing price 04:00 PM EasternExtended Trading$54.62 -0.20 (-0.37%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.NIO NYSE:NIO$5.86 -0.01 (-0.09%) Closing price 03:58 PM EasternExtended Trading$5.86 -0.01 (-0.17%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NIO Inc. designs, manufactures, and sells electric vehicles in the People's Republic of China. The company is also involved in the manufacture of e-powertrain, battery packs, and components; and racing management, technology development, and sales and after-sales management activities. In addition, it offers power solutions for battery charging needs; and other value-added services. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.Twilio NYSE:TWLO$201.74 +4.67 (+2.37%) Closing price 03:59 PM EasternExtended Trading$201.71 -0.02 (-0.01%) As of 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Twilio Inc., together with its subsidiaries, provides customer engagement platform solutions in the United States and internationally. It operates through two segments, Twilio Communications and Twilio Segment. The company provides various application programming interfaces and software solutions for communications between customers and end users, including messaging, voice, email, flex, marketing campaigns, and user identity and authentication. It also offers software products to build direct, personalized relationships with their end users, such as segment, a platform that provides tools for first-party data by unifying real-time information collected; and engage, an automation platform for the delivery of omnichannel campaigns. Twilio Inc. was incorporated in 2008 and is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
